Kazuhiro Sase
Overview
Explore the profile of Kazuhiro Sase including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
451
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miyazato K, Ohtsu H, Shimomura A, Yonemoto N, Shimizu C, Sase K, et al.
Breast
. 2025 Feb;
80:103894.
PMID: 39947088
No abstract available.
2.
Miyazato K, Ohtsu H, Shimomura A, Yonemoto N, Shimizu C, Sase K, et al.
Breast
. 2025 Jan;
79:103871.
PMID: 39754790
Standard trastuzumab therapy can reduce the risk of early recurrence of HER2-positive breast cancer. However, trastuzumab-induced cardiac dysfunction may force the discontinuation of adjuvant trastuzumab therapy. Incidentally, there are still...
3.
Merseburger A, Bakshi G, Chen D, Chiong E, Jabbour M, Joung J, et al.
World J Urol
. 2024 Mar;
42(1):156.
PMID: 38483562
Purpose: Androgen deprivation therapy (ADT) is the mainstay approach for prostate cancer (PCa) management. However, the most commonly used ADT modality, gonadotropin-releasing hormone (GnRH) agonists, has been associated with an...
4.
Makita S, Yasu T, Akashi Y, Adachi H, Izawa H, Ishihara S, et al.
Circ J
. 2023 May;
87(6):937.
PMID: 37225499
No abstract available.
5.
Kataoka Y, Yasuda S, Asaumi Y, Honda S, Noguchi T, Miyamoto Y, et al.
J Diabetes Complications
. 2023 Mar;
37(5):108469.
PMID: 36996727
Aims: To elucidate the long-term cardiovascular benefit of lowering postprandial hyperglycemia (PPG) in early-stage T2DM patients. Methods: This 10-year post-trial follow-up study included 243 patients from the DIANA (DIAbetes and...
6.
Sase K, Mukai M, Fujiwara Y
JACC CardioOncol
. 2023 Mar;
5(1):145-148.
PMID: 36875908
No abstract available.
7.
Makita S, Yasu T, Akashi Y, Adachi H, Izawa H, Ishihara S, et al.
Circ J
. 2022 Dec;
87(1):155-235.
PMID: 36503954
No abstract available.
8.
Ohtsu H, Shimomura A, Miyazaki S, Yonemoto N, Ueda S, Shimizu C, et al.
Open Heart
. 2022 Aug;
9(2).
PMID: 35995458
Objective: Adjuvant chemotherapy with trastuzumab improves the postoperative life expectancy of women with early-stage breast cancer. Although trastuzumab is reportedly cardiotoxic, quantification based on real-world evidence is lacking. Therefore, in...
9.
Kimura Y, Ohtsu H, Yonemoto N, Azuma N, Sase K
BMJ Surg Interv Health Technol
. 2022 Aug;
4(1):e000131.
PMID: 35989874
Objectives: Endovascular aortic repair (EVAR) evolved through competition with open aortic repair (OAR) as a safe and effective treatment option for appropriately selected patients with abdominal aortic aneurysm (AAA). Although...
10.
Furukawa A, Tamura Y, Taniguchi H, Kawamura A, Nagase S, Hayashi A, et al.
J Cardiol
. 2022 Aug;
81(1):63-67.
PMID: 35953399
Background: Immune checkpoint inhibitors (ICIs) improve clinical outcomes in various cancers, but sometimes induce autoimmune adverse effects, including myocarditis, which is the most serious complication. There are many reports on...